Notably, besides tumors with clear‐cut loss of nuclear MSH2/MSH6 staining, one tumor retained focal MSH2 expression and some showed heterogeneous MSH2 and/or MSH6 cytoplasmic staining (Figure 1a). The gene discussed is MSH6; the disease is neoplasm.